Hopefully, the EMA meeting confirmation is one of the last requirements before the final agreement is signed.
An announcement after the close tomorrow would be ideal.
"This may allow Leo to dicker a bit longer on IBD to get a much better deal which I am all for if a couple of months would mean a much more lucrative deal.
I had heard that this mtg with EMA and their approval/requirements for the P3 to be compatible w/ the USA P3 (so that patients in both trials can be used in the other trial) was upcoming and now we know the sources were right on the money.
More continued great news from the company and another major step towards our first P3, first partnership, and finally some cash in the bank."
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links